| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 08/18/2004 | CN1162427C Amine derivatives compounds as medicament and its salts and esters used for medicine |
| 08/18/2004 | CN1162185C Application of matrix metalloprotease tissue inhibitor in preparing medicine for preventing and treating arthritis |
| 08/18/2004 | CN1162184C Methods and compositions for specific coagulation of vasculature |
| 08/18/2004 | CN1162163C Chinese herbal medicinal liquor for curing rheumatic arthritis |
| 08/18/2004 | CN1162153C Benzothiophenes series, formulations containing same, and methods |
| 08/18/2004 | CN1162096C Potassium calcium citrate compositions and methods for production |
| 08/17/2004 | US6777577 Anticancer agents; antidiabetic agents, anticholesterol agents, cardiovascular disorders, osteoporosis |
| 08/17/2004 | US6777557 Method and composition for rejuvenating cells, tissues organs, hair and nails |
| 08/17/2004 | US6777427 Tetrahydroquinoline compounds |
| 08/17/2004 | US6777424 Administering to a patient having or at risk of having osteoarthritis, a therapeutically effective amount of an bicyclicaromatic or heteroaromatic compound containing amine and hydroxy groups |
| 08/17/2004 | US6777409 For therapy of inflammation |
| 08/17/2004 | US6777408 Pyrido-thieno-diazepines method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines |
| 08/17/2004 | CA2334257C Treatment of osteoporosis with ep2/ep4 receptor selective agonists |
| 08/17/2004 | CA2325371C Method of increasing bone toughness and stiffness and reducing fractures |
| 08/17/2004 | CA2212010C Extracts of shark cartilage, process of production and uses thereof |
| 08/17/2004 | CA2122908C Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones |
| 08/12/2004 | WO2004067741A1 Transcriptional activator |
| 08/12/2004 | WO2004067568A2 Human il-1 beta antagonists |
| 08/12/2004 | WO2004067550A2 Novel use of mifepristone and derivatives thereof as hedgehog protein signalling pathway modulators and applications of same |
| 08/12/2004 | WO2004067526A1 CRYSTAL OF (23S)-1α-HYDROXY-27-NOR-25-METHYLENEVITAMIN D3-26,23-LACTONE AND PROCESS FOR PRODUCING THE SAME |
| 08/12/2004 | WO2004067063A2 Improved formulations for transmucosal vaginal delivery of bisphosphonates |
| 08/12/2004 | WO2004067027A2 Osteogenic composition |
| 08/12/2004 | WO2004067016A1 Use of a nano-copper powder in preparation of the medicaments in preventing and treating of osteoporosis and fracture |
| 08/12/2004 | WO2004067008A1 Receptor agonists |
| 08/12/2004 | WO2004052888A3 Tropane esters and methods for producing and using them |
| 08/12/2004 | WO2004052286A3 Tyrosine kinase inhibitors |
| 08/12/2004 | WO2004048368A3 Heteroarylsulfonylmethyl hydroxamic acids and amides and their use as protease inhibitors |
| 08/12/2004 | WO2004041867A3 Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders |
| 08/12/2004 | WO2004022032A3 Pharmaceutical dosage form comprising a sulfite compound |
| 08/12/2004 | WO2004011611A3 Taci antibodies and uses thereof |
| 08/12/2004 | WO2003057133A9 Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders |
| 08/12/2004 | WO2003029293A3 Modulators of notch ic protease activity for use in immunotherapy |
| 08/12/2004 | US20040158076 Tyrosine derivatives |
| 08/12/2004 | US20040158071 Novel benzylpiperidine compound |
| 08/12/2004 | US20040158045 Nucleotide sequences coding tumor necrosis factor binding proteins for prevention and treatment of bone disorders |
| 08/12/2004 | US20040157930 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 08/12/2004 | US20040157914 Pyrrolidinone derivatives |
| 08/12/2004 | US20040157909 Modulating protein kinase signal transduction; anticancer agents |
| 08/12/2004 | US20040157894 Thiol compounds, their production and use |
| 08/12/2004 | US20040157893 Pyrazole compounds useful as protein kinase inhibitors |
| 08/12/2004 | US20040157889 Potassium and sodium channel moderators; brain disorders; strokes; multiple sclerosis |
| 08/12/2004 | US20040157888 Method of treating of demyelinating diseases or conditions |
| 08/12/2004 | US20040157868 Use of 4-substituted tetrahydropyridines for the manufacture of medicaments acting upon TGF-beta 1 |
| 08/12/2004 | US20040157862 estrogen agonist/antagonist is (-)-cis-6-phenyl-5-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-5,6,7,8-tetrahydronaphthalene-2-ol; A kit for use by a consumer to treat osteoarthritis, the kit comprising: estrogen agonist/antagonist; COX-2 inhibitor |
| 08/12/2004 | US20040157858 Piperazine derivatives as tachykinin antagonists |
| 08/12/2004 | US20040157854 CCRS antagonists useful for treating aids |
| 08/12/2004 | US20040157853 Thiazolopytimidines and their use as modulators of chemokine receptor activity |
| 08/12/2004 | US20040157843 Use of 2-amino-thiazoline derivatives as inhibitors of inducible no-synthase |
| 08/12/2004 | US20040157828 Protease inhibitors |
| 08/12/2004 | US20040157827 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 08/12/2004 | US20040157812 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 08/12/2004 | US20040157799 Pharmaceutical uses of bisphosphonates |
| 08/12/2004 | US20040157798 Drug for use in bone grafting |
| 08/12/2004 | US20040157788 production of antibodies containing K light chains, in order to provide high affinity reproducibly |
| 08/12/2004 | US20040157783 co-administration of a glutathione precursor (N-acetyl cysteine or alpha -lipoic acid) and hydroxocobalamin (a derivative of Vitamin B12) to patients with a functional Vitamin B12 deficiency and suffering from a neuropsychiatric abnormality |
| 08/12/2004 | US20040157778 computer program, which can be used for obtaining optimized dosage regimens for a desired pharmacodynamic response |
| 08/12/2004 | US20040157776 Method of treating inflammation in the joints of a body |
| 08/12/2004 | US20040157772 Use of a gatran for the manufacture of a medicament of the treatment of pulmonary fibrosis |
| 08/12/2004 | US20040157329 Transfecting chondrocytes and other mesenchymal cells with vectors comprising genes capable of stimulating chondrogenesis, osteogenesis, growth, repair, regeneration and/or restoration of the cellular matrix |
| 08/12/2004 | US20040157282 Regulation of human dual specificity protein phosphatase 7-like protein |
| 08/12/2004 | US20040157259 Novel human ion channel protein and polynucleotides encoding the same |
| 08/12/2004 | US20040157073 Lubricious coatings for substrates |
| 08/12/2004 | US20040156900 core of an active agent and a swelling agent, and a coating of film forming polymer, which swells when it imbibes fluid from the core and ruptures to release the drug in a pulse in a reliable manner |
| 08/12/2004 | US20040156887 Stabilized dispersion of phytosterol in oil |
| 08/12/2004 | US20040156834 use in bone marrow transplantation, into bone marrow cavity or into extraskeletal sites, such as the kidney capsule, muscles, liver, abdominal wall; treatment of diseases affecting the stromal microenvironment that controls hematopoiesis |
| 08/12/2004 | CA2514575A1 Crystal of (23s)-1.alpha.-hydroxy-27-nor-25-methylenevitamin d3-26,23-lactone and process for producing the same |
| 08/12/2004 | CA2514547A1 Receptor agonists |
| 08/12/2004 | CA2514109A1 Improved formulations for transmucosal vaginal delivery of bisphosphonates |
| 08/12/2004 | CA2513712A1 Osteogenic composition |
| 08/12/2004 | CA2509136A1 Human il-1 beta antagonists |
| 08/12/2004 | CA2508340A1 Transcriptional activator |
| 08/11/2004 | EP1445258A1 Activator for peroxisome proliferator-activated receptor delta |
| 08/11/2004 | EP1444330A1 Expansion of t cells in vitro and expanded t cell populations |
| 08/11/2004 | EP1444262A2 Growth hormone variations in humans and their uses |
| 08/11/2004 | EP1444251A1 Cyclic peptides as g-protein-coupled receptor antagonists |
| 08/11/2004 | EP1444232A1 Phenyl substituted triazoles and their use as selective inhibors of akl5 kinase |
| 08/11/2004 | EP1444231A1 Amine salts of an integrin receptor antagonist |
| 08/11/2004 | EP1444228A2 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors |
| 08/11/2004 | EP1444227A1 Thiazolyl substituted triazoles as alk5 inhibitors |
| 08/11/2004 | EP1444226A1 Compounds useful as reversible inhibitors of cysteine proteases |
| 08/11/2004 | EP1444219A1 Substituted piperidines and their use for the treatment of diseases related to the histamine h3 receptor |
| 08/11/2004 | EP1444207A2 Substituted pyrazolyl-compounds for the treatment of inflammation |
| 08/11/2004 | EP1444204A1 Protein kinase and phosphatase inhibitors, methods for designing them, and methods of using them |
| 08/11/2004 | EP1444203A1 Cannabinoid receptor ligands |
| 08/11/2004 | EP1444202A1 Novel metalloproteinase inhibitors |
| 08/11/2004 | EP1444009A1 Treatment of insulin resistance syndrome and type 2 diabetes with pde9 inhibitors |
| 08/11/2004 | EP1443961A2 Glycoprotein compositions |
| 08/11/2004 | EP1443945A1 Use of a mixture of sodium hyaluronate and chondroitin sulfate for the treatment of osteoarthritis |
| 08/11/2004 | EP1443943A1 Process for reacting alkaloids and use of the reaction products in the preparation of medicaments |
| 08/11/2004 | EP1443937A1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer |
| 08/11/2004 | EP1443935A2 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors |
| 08/11/2004 | EP1443925A1 Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
| 08/11/2004 | EP1443918A1 Calcium l-threonate for preventing or treating bone facture |
| 08/11/2004 | EP1443915A1 Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes |
| 08/11/2004 | EP1358182B1 Diazocine derivatives and their use as tryptase inhibitors |
| 08/11/2004 | EP1155003B1 Novel guanidine derivatives as inhibitors of cell adhesion |
| 08/11/2004 | EP1147095B1 2, 3, 4, 5-tetrahydro-1h-[1, 4] benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors |
| 08/11/2004 | CN1520424A Immunoglobulins 2 |
| 08/11/2004 | CN1520409A Piperazine oxime derivatives having Nk-1 receptor antagonistic activity |
| 08/11/2004 | CN1520401A Calcilytic compounds |